Go Symbol Lookup
Loading...

AIG Chairman to Step In as Interim CEO If Needed

 Text Size  
Published: Wednesday, 27 Oct 2010 | 5:38 PM ET
By: CNBC.com with Reuters

American International Group said Wednesday its Chairman Steve Miller would serve as interim chief executive if Robert Benmosche, who has been diagnosed with cancer, steps down.

Getty Images
Robert Benmosche

AIG also said that its board is working on succession plans and reviewing the selection criteria for its next CEO. Chairman Miller would serve as interim chief in the meantime.

The bailed-out insurer said on Monday that Benmosche has cancer and is undergoing aggressive chemotherapy. AIG said Benmosche intends to work a full schedule during his treatment, but it is also making contingency plans.

"We are committed to management continuity and ensuring that we have established appropriate, orderly succession plans," the board said in a statement after a meeting on Wednesday.

 Print
American International Group said Wednesday its Chairman Steve Miller would serve as interim chief executive if Robert Benmosche, who has been diagnosed with cancer, steps down.
  Price   Change %Change
AFF ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

U.S. Video

  • Discussing the state of Detroit's economy, with CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum.

  • Larry Kudlow discusses the journalistic merit of a Financial Times article, which triggered a brief sell-off in U.S markets. Larry McDonald, Newedge; Ed Butowsky, Chapwood Investments; and Ron Kruszewski, Stifel Nicolaus join in the discussion later.

  • The Supreme Court ruled today that the FTC can keep challenging "pay to delay" deals between pharmaceutical companies and generic drugmakers. CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum, discuss.